Insulet

Insulet Omnipod 5 Receives FDA Clearance for Enhanced Algorithm Features

银休特

Insulet's 15-minute chart sees MACD and KDJ Death Cross signals.

Goldman Sachs

Provident Financial

Growth Stocks to Watch and One to Sell: Provident Financial Services (PFS) vs. Insulet (PODD) and Goldman Sachs (GS)

Coupang

Amphenol

Three Quality Compounders to Keep an Eye On: Coupang, Insulet, and Amphenol

Insulet's 15min chart shows RSI Oversold, KDJ Golden Cross

Catalyst<ul> <li>Most analysts rate PODD Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state and the direction is not clear enough.</li> <li>Recent technical signals are scarce and the market is relatively calm.</li> <li>Fund flows show negative trends for Small, Medium, and Large orders, indicating potential selling pressure.</li></ul>

Key Factors

Insulet Corporation received FDA clearance for enhanced algorithm features in the Omnipod 5 Automated Insulin Delivery System.

Recent Updates

PODD News